NYMXF — Nymox Pharmaceutical Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Nymox Pharmaceutical Reports Qtrly Net Loss Per Share Basic & Diluted of $0.05
Brief: Nymox Pharmaceutical Corp QTRLY Loss Per Share $0.03
Brief: Nymox Pharmaceutical Files For Resale Of 3.7 Mln Common Shares
Brief: Nymox Provides Update On Regulatory Activities
Brief: Nymox Pharmaceutical Corp Announces $9 Million Registered Direct Offering
Brief: Nymox Announces $9 Million Registered Direct Offering
Brief: Nymox Says Filed With The Regulatory Authorities For New Trademark Brand Names For FT In Different Jurisdictions Including U.S. and Europe
Brief: Nymox Updates Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
Brief: Nymox Pharmaceutical Files For Mixed Shelf Offering Of Up To $12 Million
Brief: Nymox Provides Update On Current Corporate Activities
U.S. STOCKS ON THE MOVE-Oil and chip stocks, Lumber Liquidators, Delta Air Lines, Starbucks, GE, Lululemon
Brief: Nymox Reports On Newly Issued Patents And Corporate Developments
Brief: Nymox Pharmaceutical Corp Qtrly Loss Per Share $0.05
Brief: Nymox Pharmaceutical Corp Provides Update On Core Activities
Nymox Pharma: Up on long-term safety data of lead drug
Brief: Nymox Reports Safety Benefits Of Fexapotide Treatments For Prostate Cancer And Benign Prostatic Hyperplasia
Brief: Nymox Pharmaceutical Corp QTRLY Loss Per Share $0.04
Brief: Nymox Announces Expanded Marketing Plans
Brief: Nymox Announces Relocation Of Company Headquarters To Switzerland